Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Clinical trial NCT02350517 · COMPLETED

Trial details

NCT number: NCT02350517
Sponsor: Yuhong Li
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2015-01-01
Primary completion: 2019-12-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.